200 Participants Needed

Obstacle Negotiation Training for Low Vision

KA
Overseen ByKierstyn A Napier-Dovorany, OD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Falls are common among people with vision impairment and can lead to devastating health consequences. Understanding the functions of vision and how the visual characteristics of obstacles in the walking path impact the gait of people with vision impairment is necessary to create strategies to prevent falls in this population. The purpose of this study is to determine how adults with vision impairment change their gait behavior when stepping over obstacles that vary in height and contrast to the ground. We will then determine the mechanisms of gaze behavior that correlate to the gait behavior.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Obstacle characteristics for low vision?

The standardized obstacle course study shows that training with obstacle courses can improve mobility function, as participants demonstrated changes in walking speed and error rates after training. This suggests that obstacle negotiation training could be effective for people with low vision by enhancing their ability to navigate environments safely.12345

Is obstacle negotiation training for low vision safe for humans?

The research suggests that obstacle negotiation training, including virtual reality-based training, is generally safe for individuals with low vision. Studies have shown improvements in safety during street crossing after training, indicating that the training methods do not pose significant safety risks.36789

How does Obstacle Negotiation Training for Low Vision differ from other treatments for low vision?

Obstacle Negotiation Training for Low Vision is unique because it focuses on improving mobility by training individuals to better detect and navigate around obstacles, rather than relying solely on traditional aids like canes. This approach may enhance personal independence by presenting the visual environment in a way that makes it easier to identify obstacles, which is different from other treatments that may not address obstacle negotiation directly.37101112

Eligibility Criteria

This trial is for adults over 18 who can walk on their own. It's for those with normal vision or impaired vision, defined as having a visual acuity of 20/25 or worse, possibly with central scotoma, or a restricted field of view. People not allowed include those advised against moderate exercise by doctors, have vestibular disorders or deafness, conditions affecting long walks, cognitive issues (scoring below 24 out of 30 on the Mini Mental State Exam), gait abnormalities from injuries or diseases like Parkinson's, and non-English speakers.

Inclusion Criteria

I can walk on my own without help.
I am 18 years old or older.
You can see normally, or you have impaired vision, meaning your eyesight is 20/25 or worse with or without a central blind spot, and your field of vision is limited to an average of 100 degrees or less.
See 1 more

Exclusion Criteria

I have a history of balance issues or deafness.
I can walk for up to 2 hours with breaks without feeling dizzy, chest pain, or shortness of breath.
I am not cleared for moderate exercise by a doctor.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Intervention

Participants perform a series of short walking trials with obstacles of varying height and contrast

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the intervention

2-4 weeks

Treatment Details

Interventions

  • Obstacle characteristics
Trial OverviewThe study tests how adults with vision impairment adjust their walking when they encounter obstacles that differ in height and contrast to the ground. The goal is to understand how these individuals use their gaze and change their gait to navigate safely and potentially reduce fall risks.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Low Vision GroupExperimental Treatment1 Intervention
At a single study visit, the group of low vision participants will be asked to perform a series of short walking trials. During each trial they will walk at a self-selected speed along a walkway (6 meters in length) that may or may not contain an obstacle to step over. The trials will be randomly varied with regard to an obstacle's presence, height, and contrast from the walkway surface. Repeated trials of each condition variation will be performed during the visit.
Group II: Control GroupActive Control1 Intervention
At a single study visit, the group of age-matched participants without low vision will be asked to perform a series of short walking trials. During each trial they will walk at a self-selected speed along a walkway (6 meters in length) that may or may not contain an obstacle to step over. The trials will be randomly varied with regard to an obstacle's presence, height, and contrast from the walkway surface. Repeated trials of each condition variation will be performed during the visit.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

Findings from Research

A study involving 316 low-vision patients and 38 clinicians found that clinicians' predictions of the success of low-vision rehabilitation (LVR) did not correlate with the actual self-reported outcomes of patients, indicating a disconnect between clinician expectations and patient experiences.
Clinicians' predictions were influenced by patients' cognitive functioning and a combination of visual acuity and functional ability, but these predictions were not reliable, as they showed no better agreement with patient outcomes than chance.
Comparison of clinician-predicted to measured low vision outcomes.Chan, TL., Goldstein, JE., Massof, RW.[2021]
The LOVIT II trial is a multicenter randomized controlled trial involving 330 patients with macular disease, aiming to compare the effectiveness of low vision rehabilitation (LVR) with basic low vision (LV) services.
Preliminary results show that LVR, which includes therapy sessions to teach effective use of vision aids, may lead to better improvements in visual reading ability compared to basic LV, where devices are simply dispensed without additional training.
VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision.Stelmack, JA., Tang, XC., Reda, DJ., et al.[2015]
A standardized indoor course was developed to effectively evaluate obstacle avoidance in individuals with ultralow vision, involving 36 blind participants and 6 sighted controls across multiple trials.
The course proved to be a feasible and cost-effective method for testing mobility function, showing significant differences in performance metrics like percent error and preferred walking speed across different course iterations.
A standardized obstacle course for assessment of visual function in ultra low vision and artificial vision.Nau, AC., Pintar, C., Fisher, C., et al.[2021]

References

Comparison of clinician-predicted to measured low vision outcomes. [2021]
VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision. [2015]
A standardized obstacle course for assessment of visual function in ultra low vision and artificial vision. [2021]
Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. [2022]
Visual field size criteria for mobility rehabilitation referral. [2022]
Orientation and mobility outcome measures. [2021]
Mobility performance of low-vision adults using an electronic mobility aid. [2015]
Individuals with severely impaired vision can learn useful orientation and mobility skills in virtual streets and can use them to improve real street safety. [2022]
Structured Laser Light Improves Tripping Hazard Recognition for People with Visual Impairments. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Visual accessibility of ramps and steps. [2021]
Mobility scooter driving ability in visually impaired individuals. [2018]
12.United Statespubmed.ncbi.nlm.nih.gov
Improving Mobility Performance in Low Vision With a Distance-Based Representation of the Visual Scene. [2022]